-
Efficacy of neoadjuvant treatment with or without pertuzumab in patients with stage II and III HER2-positive breast cancer: a nationwide cohort analysis of pathologic response and 5-year survival
van der Voort, A., Liefaard, M. C., van Ramshorst, M. S., van Werkhoven, E., Sanders, J., Wesseling, J., Scholten, A., Vrancken Peeters, M. J. T. F. D., de Munck, L., Siesling, S. & Sonke, G. S., 1 Oct 2022, In: Breast (Edinburgh, Scotland). 65, p. 110-115 6 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
